Charles B. O'Keeffe - 24 Jan 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Charles B. O'Keeffe
Issuer symbol
CPRX
Transactions as of
24 Jan 2023
Net transactions value
+$39,500
Form type
4
Filing time
27 Jan 2023, 15:30:35 UTC
Previous filing
29 Dec 2022
Next filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $39,500 +50,000 +8.8% $0.7900* 616,391 24 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -16% $0.000000 264,500 24 Jan 2023 Common Stock 50,000 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vested in two equal tranches on June 15, 2017 and June 15, 2018.